Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Dyslipidemia

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 75 articles: HTML format

Single Articles

February 2024
1. MAGNO S, Ceccarini G, Corvillo F, Pelosini C, et al
   Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study.
   J Clin Endocrinol Metab. 2024;109:e932-e944.
   PubMed     Abstract available
   
   
   
2. HEDEGAARD BS, Nordestgaard BG, Kanstrup HL, Thomsen KK, et al
   High Lipoprotein(a) May Explain One-Quarter of Clinical Familial Hypercholesterolemia Diagnoses in Danish Lipid Clinics.
   J Clin Endocrinol Metab. 2024;109:659-667.
   PubMed     Abstract available
   
   
   
3. BESCI O, Foss de Freitas MC, Guidorizzi NR, Guler MC, et al
   Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.
   J Clin Endocrinol Metab. 2024;109:e1204-e1224.
   PubMed     Abstract available
   
   
   
4. U-DIN M, Ahmed BA, Syed SA, Ong FJ, et al
   Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults.
   J Clin Endocrinol Metab. 2024;109:680-690.
   PubMed     Abstract available
   
   
   December 2023
5. ALVAREZ-JIMENEZ L, Morales-Palomo F, Moreno-Cabanas A, Ortega JF, et al
   Acute Statin Withdrawal Does not Interfere With the Improvements of a Session of Exercise in Postprandial Metabolism.
   J Clin Endocrinol Metab. 2023;109:80-91.
   PubMed     Abstract available
   
   
   November 2023
6. LI S, Cui M, Liu Y, Liu X, et al
   Metabolic profiles of type 2 diabetes and their association with renal complications.
   J Clin Endocrinol Metab. 2023 Nov 2:dgad643. doi: 10.1210.
   PubMed     Abstract available
   
   
   September 2023
7. MEYER EJ, Wittert GA
   Approach the patient with obstructive sleep apnea and obesity.
   J Clin Endocrinol Metab. 2023 Sep 27:dgad572. doi: 10.1210.
   PubMed     Abstract available
   
   
   
8. TAO X, Liu L, Ma P, Hu J, et al
   Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016.
   J Clin Endocrinol Metab. 2023 Sep 21:dgad561. doi: 10.1210.
   PubMed     Abstract available
   
   
   July 2023
9. CHEN JX, Geng T, Zhang YB, Wang Y, et al
   Associations of Clinical Risk Factors and Novel Biomarkers with Age at Onset of Type 2 Diabetes.
   J Clin Endocrinol Metab. 2023 Jul 15:dgad422. doi: 10.1210.
   PubMed     Abstract available
   
   
   May 2023
10. GRIGORYAN S, Nhan W, Zhang L, Urban C, et al
    Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
    J Clin Endocrinol Metab. 2023;108:e343-e349.
    PubMed     Abstract available
    
    
    April 2023
11. SYED-ABDUL MM, Stahel P, Zembroski A, Tian L, et al
    Glucagon-like Peptide-2 Acutely Enhances Chylomicron Secretion in Humans Without Mobilizing Cytoplasmic Lipid Droplets.
    J Clin Endocrinol Metab. 2023;108:1084-1092.
    PubMed     Abstract available
    
    
    March 2023
12. NEWMAN CB, Tobert JA
    Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol.
    J Clin Endocrinol Metab. 2023;108:784-790.
    PubMed     Abstract available
    
    
    February 2023
13. DIMAKOPOULOU A, Clarke SA, Jayasena CN
    Screening for Adverse Metabolic Consequences in Women With Idiopathic Hirsutism-Is it Relevant?
    J Clin Endocrinol Metab. 2023;108:e38-e39.
    PubMed    
    
    
    January 2023
14. HORI M, Takahashi A, Hosoda K, Ogura M, et al
    A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia.
    J Clin Endocrinol Metab. 2023;108:422-432.
    PubMed     Abstract available
    
    
    December 2022
15. BRIL F, Pearce RW, Collier TS, McPhaul MJ, et al
    Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease.
    J Clin Endocrinol Metab. 2022;108:42-51.
    PubMed     Abstract available
    
    
    
16. LIU Z, Tian Z, Zhao D, Liang Y, et al
    Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2022;108:232-249.
    PubMed     Abstract available
    
    
    
17. PAQUETTE M, Bernard S, Baass A
    Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease.
    J Clin Endocrinol Metab. 2022;108:184-190.
    PubMed     Abstract available
    
    
    October 2022
18. VADMAND AC, Nissen AA, Mathiesen S, Ebbesen MS, et al
    Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins.
    J Clin Endocrinol Metab. 2022 Oct 1. pii: 6743059. doi: 10.1210.
    PubMed     Abstract available
    
    
    September 2022
19. VALENTINE A, Davis S, Furniss A, Dowshen N, et al
    Multicenter Analysis of Cardiometabolic-related Diagnoses in Transgender and Gender-Diverse Youth: A PEDSnet Study.
    J Clin Endocrinol Metab. 2022;107:e4004-e4014.
    PubMed     Abstract available
    
    
    
20. SUN H, Zhu W, Liu J, An Y, et al
    Reduced sensitivity to thyroid hormones is associated with high remnant cholesterol levels in Chinese euthyroid adults.
    J Clin Endocrinol Metab. 2022 Sep 8. pii: 6693885. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2022
21. COSTA S, Sampaio L, Berta Sousa A, Xing C, et al
    Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2022;107:2433-2438.
    PubMed     Abstract available
    
    
    July 2022
22. CAI X, Liang N, Cai X, Zhou Q, et al
    Lipid Metabolic Genes and Maternal Supraphysiological Hypercholesterolemia: An Analysis of Maternal-fetal Interaction.
    J Clin Endocrinol Metab. 2022;107:e3134-e3144.
    PubMed     Abstract available
    
    
    
23. SHANNON CE, Merovci A, Fourcaudot M, Tripathy D, et al
    Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects.
    J Clin Endocrinol Metab. 2022;107:e3177-e3185.
    PubMed     Abstract available
    
    
    
24. OSTINELLI G, Laforest S, Denham SG, Gauthier MF, et al
    Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction.
    J Clin Endocrinol Metab. 2022;107:e3330-e3342.
    PubMed     Abstract available
    
    
    June 2022
25. DING X, Wang Y, Liu J, Wang G, et al
    Impaired sensitivity to thyroid hormones is associated with elevated homocysteine levels in the euthyroid population.
    J Clin Endocrinol Metab. 2022 Jun 16. pii: 6609259. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2022
26. MELA V, Ruiz-Limon P, Balongo M, Rad HM, et al
    Mitochondrial Homeostasis In Obesity Related Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022 May 24. pii: 6591321. doi: 10.1210.
    PubMed     Abstract available
    
    
    
27. SUBRAMANIAN S
    Approach to the Patient With Moderate Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022;107:1686-1697.
    PubMed     Abstract available
    
    
    
28. FOURMAN LT, Grinspoon SK
    Approach to the Patient With Lipodystrophy.
    J Clin Endocrinol Metab. 2022;107:1714-1726.
    PubMed     Abstract available
    
    
    April 2022
29. DAVIS SM, Nokoff NJ, Furniss A, Pyle L, et al
    Population-based Assessment of Cardiometabolic-related Diagnoses in Youth With Klinefelter Syndrome: A PEDSnet Study.
    J Clin Endocrinol Metab. 2022;107:e1850-e1859.
    PubMed     Abstract available
    
    
    
30. WANG M, Xue Q, Li X, Krohn K, et al
    Circulating Levels of microRNA-122 and Hepatic Fat Change in Response to Weight-Loss Interventions: CENTRAL Trial.
    J Clin Endocrinol Metab. 2022;107:e1899-e1906.
    PubMed     Abstract available
    
    
    
31. AGUILAR-SALINAS CA, Gomez-Diaz RA, Corral P
    New Therapies for Primary Hyperlipidemia.
    J Clin Endocrinol Metab. 2022;107:1216-1224.
    PubMed     Abstract available
    
    
    March 2022
32. GUO K, Savelieff MG, Rumora AE, Alakwaa FM, et al
    Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.
    J Clin Endocrinol Metab. 2022;107:1091-1109.
    PubMed     Abstract available
    
    
    
33. ZHANG S, Cheng S, He X, Wang W, et al
    Remnant Lipoprotein Cholesterol as a Factor Related to Adult Fatty Liver Disease.
    J Clin Endocrinol Metab. 2022;107:e1598-e1609.
    PubMed     Abstract available
    
    
    
34. EID WE, Sapp EH, Wendt A, Lumpp A, et al
    Improving Familial Hypercholesterolemia Diagnosis Using an EMR-based Hybrid Diagnostic Model.
    J Clin Endocrinol Metab. 2022;107:1078-1090.
    PubMed     Abstract available
    
    
    
35. CHUNG ST, Katz LEL, Stettler-Davis N, Shults J, et al
    The relationship between lipoproteins and insulin sensitivity in youth with obesity and abnormal glucose tolerance.
    J Clin Endocrinol Metab. 2022 Mar 3. pii: 6542083. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2022
36. STINSON SE, Jonsson AE, Fernandez de Retana Alzola I, Lund MAV, et al
    Hyperglucagonemia in pediatric adiposity associates with cardiometabolic risk factors but not hyperglycemia.
    J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537120. doi: 10.1210.
    PubMed     Abstract available
    
    
    
37. MESAS AE, Garrido-Miguel M, Fernandez-Rodriguez R, Fernandez Franco S, et al
    Egg Consumption and Blood Lipid Parameters According to the Presence of Chronic Metabolic Disorders: The EVIDENT II Study.
    J Clin Endocrinol Metab. 2022;107:e963-e972.
    PubMed     Abstract available
    
    
    
38. OSUNA-PRIETO FJ, Rubio-Lopez J, Di X, Yang W, et al
    Plasma Levels of Bile Acids Are Related to Cardiometabolic Risk Factors in Young Adults.
    J Clin Endocrinol Metab. 2022;107:715-723.
    PubMed     Abstract available
    
    
    January 2022
39. PAQUETTE M, Bernard S, Pare G, Baass A, et al
    Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE Deficiency.
    J Clin Endocrinol Metab. 2022;107:538-548.
    PubMed     Abstract available
    
    
    
40. YANG R, Xu A, Kharitonenkov A
    Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver.
    J Clin Endocrinol Metab. 2022;107:e417-e419.
    PubMed    
    
    
    
41. RADER DJ, Maratos-Flier E, Nguyen A, Hom D, et al
    LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022;107:e57-e70.
    PubMed     Abstract available
    
    
    December 2021
42. MOUSA A, Huynh K, Ellery SJ, Strauss BJ, et al
    Novel lipidomic signature associated with metabolic risk in women with and without polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2021 Dec 31. pii: 6491229. doi: 10.1210.
    PubMed     Abstract available
    
    
    
43. HA J, Park SH, Park SS, Han S, et al
    Metabolic disease incidence after allogeneic stem cell transplantation: A Korean, nationwide, case-control study.
    J Clin Endocrinol Metab. 2021 Dec 14. pii: 6461117. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2021
44. HERRERO-AGUAYO V, Saez-Martinez P, Lopez-Canovas JL, Prados-Carmona JJ, et al
    Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease.
    J Clin Endocrinol Metab. 2021;106:e4917-e4934.
    PubMed     Abstract available
    
    
    
45. ASHRAF AP, Sunil B, Bamba V, Breidbart E, et al
    Case Studies in Pediatric Lipid Disorders and Their Management.
    J Clin Endocrinol Metab. 2021;106:3605-3620.
    PubMed     Abstract available
    
    
    October 2021
46. COHEN CC, Perng W, Sundaram SS, Scherzinger A, et al
    Hepatic Fat in Early Childhood Is Independently Associated With Estimated Insulin Resistance: The Healthy Start Study.
    J Clin Endocrinol Metab. 2021;106:3140-3150.
    PubMed     Abstract available
    
    
    
47. NGUYEN ML, Sachdev V, Burklow TR, Li W, et al
    Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.
    J Clin Endocrinol Metab. 2021;106:e4327-e4339.
    PubMed     Abstract available
    
    
    
48. TSABAN G, Yaskolka Meir A, Zelicha H, Rinott E, et al
    Diet-induced fasting ghrelin elevation reflects the recovery of insulin sensitivity and visceral adiposity regression.
    J Clin Endocrinol Metab. 2021 Oct 13. pii: 6382201. doi: 10.1210.
    PubMed     Abstract available
    
    
    September 2021
49. AGUILAR-RAMIREZ D, Alegre-Diaz J, Herrington WG, Staplin N, et al
    Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults.
    J Clin Endocrinol Metab. 2021;106:2828-2839.
    PubMed     Abstract available
    
    
    August 2021
50. WANG J, Wang Z, Guo F, Zhang Y, et al
    Individual and combined cardiometabolic morbidities and the subsequent risk of cardiovascular events in Chinese adults.
    J Clin Endocrinol Metab. 2021 Aug 24. pii: 6357056. doi: 10.1210.
    PubMed     Abstract available
    
    
    
51. PAQUETTE M, Amyot J, Fantino M, Baass A, et al
    Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    J Clin Endocrinol Metab. 2021;106:e3473-e3482.
    PubMed     Abstract available
    
    
    July 2021
52. YU D, Wang Z, Zhang X, Qu B, et al
    Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and incident diabetic nephropathy.
    J Clin Endocrinol Metab. 2021 Jul 22. pii: 6325383. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2021
53. MIYAMURA K, Nawa N, Isumi A, Doi S, et al
    The Association of Passive Smoking and Dyslipidemia Among Adolescence in Japan: Results From A-CHILD Study.
    J Clin Endocrinol Metab. 2021;106:e2738-e2748.
    PubMed     Abstract available
    
    
    April 2021
54. KIYA M, Tamura Y, Takeno K, Someya Y, et al
    Adipose Insulin Resistance and Decreased Adiponectin Are Correlated With Metabolic Abnormalities in Nonobese Men.
    J Clin Endocrinol Metab. 2021;106:e2228-e2238.
    PubMed     Abstract available
    
    
    March 2021
55. BELHASSEN M, Van Ganse E, Nolin M, Berard M, et al
    10-Year Comparative Follow-up of Familial versus Multifactorial Chylomicronemia Syndromes.
    J Clin Endocrinol Metab. 2021;106:e1332-e1342.
    PubMed     Abstract available
    
    
    
56. GRANT LK, Czeisler CA, Lockley SW, Rahman SA, et al
    Time-of-day and Meal Size Effects on Clinical Lipid Markers.
    J Clin Endocrinol Metab. 2021;106:e1373-e1379.
    PubMed     Abstract available
    
    
    
57. YEN CL, Fan PC, Lin MS, Lee CC, et al
    Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156972. doi: 10.1210.
    PubMed     Abstract available
    
    
    
58. MORYS F, Dadar M, Dagher A
    Association between mid-life obesity, its metabolic consequences, cerebrovascular disease and cognitive decline.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156963. doi: 10.1210.
    PubMed     Abstract available
    
    
    
59. TORKY A, Sinaii N, Jha S, Desai J, et al
    Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156969. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2021
60. STINSON SE, Jonsson AE, Lund MAV, Frithioff-Bojsoe C, et al
    Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents.
    J Clin Endocrinol Metab. 2021 Feb 17. pii: 6141463. doi: 10.1210.
    PubMed     Abstract available
    
    
    
61. NGAOSUWAN K, Johnston DG, Godsland IF, Cox J, et al
    Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities.
    J Clin Endocrinol Metab. 2021 Feb 15. pii: 6135110. doi: 10.1210.
    PubMed     Abstract available
    
    
    
62. MORAN C, McEniery CM, Schoenmakers N, Mitchell C, et al
    Dyslipidemia, insulin resistance, ectopic lipid accumulation and vascular function in Resistance to Thyroid Hormone beta.
    J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125725. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2021
63. LUUKKONEN PK, Qadri S, Lehtimaki TE, Juuti A, et al
    The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.
    J Clin Endocrinol Metab. 2021;106:e300-e315.
    PubMed     Abstract available
    
    
    December 2020
64. NEWMAN CB, Blaha MJ, Boord JB, Cariou B, et al
    Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    October 2020
65. FERCHAUD-ROUCHER V, Zair Y, Aguesse A, Krempf M, et al
    Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    September 2020
66. KOTWAL A, Cortes T, Genere N, Hamidi O, et al
    Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2020 Sep 21. pii: 5909289. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2020
67. KOZAKOVA M, Morizzo C, Penno G, Shore AC, et al
    Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846189. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2020
68. MORALES-PALOMO F, Ramirez-Jimenez M, Ortega JF, Moreno-Cabanas A, et al
    Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    
69. LANGSTED A, Jensen AMR, Varbo A, Nordestgaard BG, et al
    Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    March 2020
70. FANG S, Zhang S, Huang Y, Wu Y, et al
    Evidence for associations between Th1/Th17 "hybrid" phenotype and altered lipometabolism in very severe Graves' orbitopathy.
    J Clin Endocrinol Metab. 2020 Mar 16. pii: 5805506. doi: 10.1210.
    PubMed     Abstract available
    
    
    
71. HSIUNG CN, Chang YC, Lin CW, Chang CW, et al
    The Causal Relationship of Circulating Triglyceride and Glycated Hemoglobin: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    January 2020
72. KELSEY MM, Pyle L, Hilkin A, Severn CD, et al
    The impact of obesity on insulin sensitivity and secretion during pubertal progression: a longitudinal study.
    J Clin Endocrinol Metab. 2020 Jan 30. pii: 5717690. doi: 10.1210.
    PubMed     Abstract available
    
    
    
73. SHAH VN, Bailey R, Wu M, Foster NC, et al
    Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    J Clin Endocrinol Metab. 2020 Jan 19. pii: 5709622. doi: 10.1210.
    PubMed     Abstract available
    
    
    December 2019
74. HIGGINS V, Omidi A, Tahmasebi H, Asgari S, et al
    Marked influence of adiposity on laboratory biomarkers in a healthy cohort of children and adolescents.
    J Clin Endocrinol Metab. 2019 Dec 17. pii: 5675353. doi: 10.1210.
    PubMed     Abstract available
    
    
    
75. HIGGINS V, Asgari S, Hamilton JK, Wolska A, et al
    Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity.
    J Clin Endocrinol Metab. 2019 Dec 11. pii: 5673404. doi: 10.1210.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.